NVCRNovoCure Limited Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 19405
Ticker: NVCR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-10-02
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: NVCR

Detail

Enriched 2026-08-14 20:47

Market cap: $2,048,282,325.6
Shares outstanding (class): 116,445,840
Shares outstanding (weighted): 116,445,840
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 1,605
Location: ST. HELIER
Homepage: https://www.novocure.com
Description: NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Market cap and share counts drift.

Funds holding this security

98 funds · 101 positions · $181.44M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$36.61M	0.00%	3,359,159 NS	TICKER
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$27.18M	0.02%	2,493,993 NS	TICKER
iShares Russell 2000 ETF iShares Trust	IWM	$27.09M	0.04%	2,485,300 NS	TICKER
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$15.19M	0.04%	1,393,941 NS	TICKER
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$12.36M	0.02%	1,134,271 NS	TICKER
iShares Russell 2000 Growth ETF iShares Trust	IWO	$9.02M	0.07%	827,769 NS	TICKER
iShares Biotechnology ETF iShares Trust	IBB	$8.32M	0.10%	763,201 NS	TICKER
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$5.27M	0.06%	483,400 NS	TICKER
iShares U.S. Medical Devices ETF iShares Trust	IHI	$4.78M	0.15%	438,226 NS	TICKER
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$3.56M	0.04%	327,034 NS	TICKER
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$2.70M	0.11%	247,388 NS	TICKER
BlackRock Health Sciences Term Trust —	—	$2.29M	0.23%	210,016 NS	TICKER
State Street(R) SPDR(R) S&P(R) Health Care Equi… SPDR SERIES TRUST	XHE	$2.03M	1.50%	186,356 NS	TICKER
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.73M	0.04%	158,485 NS	TICKER
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.43M	0.00%	131,455 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERNVCR
CIK0001645113
ISINJE00BYSS4X48
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Medical Devices
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: NovoCure develops medical devices for cancer treatment, fitting the medical devices industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.